DocuSign, Inc. (NASDAQ:DOCU) Director Teresa Briggs Sells 534 Shares

DocuSign, Inc. (NASDAQ:DOCU) Director Teresa Briggs sold 534 shares of the business’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

DocuSign Trading Down 2.7 %

Shares of DOCU opened at $83.43 on Tuesday. The company’s 50 day simple moving average is $87.82 and its 200-day simple moving average is $79.69. The firm has a market cap of $16.85 billion, a PE ratio of 17.20, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same period in the previous year, the business posted $0.76 earnings per share. DocuSign’s quarterly revenue was up 9.0% on a year-over-year basis. As a group, equities research analysts forecast that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Analysts Set New Price Targets

DOCU has been the topic of a number of recent analyst reports. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a research report on Friday. Wells Fargo & Company raised their price target on DocuSign from $70.00 to $73.00 and gave the company an “underweight” rating in a research note on Friday. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Bank of America cut their target price on DocuSign from $112.00 to $98.00 and set a “neutral” rating on the stock in a research report on Friday. Finally, UBS Group lowered their price target on DocuSign from $100.00 to $90.00 and set a “neutral” rating for the company in a report on Friday. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $95.58.

Institutional Trading of DocuSign

A number of hedge funds have recently added to or reduced their stakes in DOCU. Kestra Investment Management LLC purchased a new stake in shares of DocuSign during the fourth quarter worth approximately $30,000. First Horizon Advisors Inc. raised its position in DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock worth $36,000 after buying an additional 201 shares during the last quarter. Modus Advisors LLC acquired a new stake in shares of DocuSign in the 4th quarter worth $36,000. Wood Tarver Financial Group LLC purchased a new stake in shares of DocuSign in the fourth quarter valued at about $37,000. Finally, McIlrath & Eck LLC boosted its holdings in shares of DocuSign by 476.0% in the fourth quarter. McIlrath & Eck LLC now owns 432 shares of the company’s stock valued at $39,000 after acquiring an additional 357 shares in the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.